Nucleosides - RNA / BOC Sciences

(2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate

Description: (2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate is an exemplarily remarkable medication for treating chronic lymphocytic leukemia and small lymphocytic leukemia. This class of drugs known as nucleoside analogues remarkably functions by interfering with cancer cells' DNA synthesis and leads to their ultimate death.

CAT: BRP-01941

CAS: 1294481-82-5

MF: C25H19Cl3FN5O5

MF: 594.81

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, sealed storage, away from moisture and light

Density: 1.63±0.1 g/cm3

Melting Point: 171-176 °C

Boiling Point: 759.4±70.0 °C at 760 mmHg

InChIKey: CWRGPCWFCOZJTQ-NMRNUDPRSA-N

CanonicalSMILES: CC1(C(C(OC1N2C=NC3=C2N=C(N=C3Cl)N)COC(=O)C4=CC=C(C=C4)Cl)OC(=O)C5=CC=C(C=C5)Cl)F

IUPAC Name: [(2R,3R,4R,5R)-5-(2-amino-6-chloropurin-9-yl)-3-(4-chlorobenzoyl)oxy-4-fluoro-4-methyloxolan-2-yl]methyl 4-chlorobenzoate

InChI: InChI=1S/C25H19Cl3FN5O5/c1-25(29)18(39-22(36)13-4-8-15(27)9-5-13)16(10-37-21(35)12-2-6-14(26)7-3-12)38-23(25)34-11-31-17-19(28)32-24(30)33-20(17)34/h2-9,11,16,18,23H,10H2,1H3,(H2,30,32,33)/t16-,18-,23-,25-/m1/s1

Synonyms: (2R,3R,4R,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-(((4-chlorobenzoyl)oxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl 4-chlorobenzoate; 9H-Purin-2-amine, 9-[(2R)-3,5-bis-O-(4-chlorobenzoyl)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl]-6-chloro-; 9-[(2R)-3,5-Bis-O-(4-chlorobenzoyl)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl]-6-chloro-9H-purin-2-amine

Molnupiravir Dimethyl Dioxol Impurity

Description: An impurity of Molnupiravir which is an antiviral drug with promising activity against the SARS-CoV-2 virus.

CAT: BRP-01942

CAS: 2346620-55-9

MF: C16H23N3O7

MF: 369.37

Purity: 97%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.51±0.1 g/cm3

InChIKey: MNKXNZQOZRWRKB-OJAKKHQRSA-N

CanonicalSMILES: CC(C)C(=O)OCC1C2C(C(O1)N3C=CC(=NC3=O)NO)OC(O2)(C)C

IUPAC Name: [(3aR,4R,6R,6aR)-4-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate

InChI: InChI=1S/C16H23N3O7/c1-8(2)14(20)23-7-9-11-12(26-16(3,4)25-11)13(24-9)19-6-5-10(18-22)17-15(19)21/h5-6,8-9,11-13,22H,7H2,1-4H3,(H,17,18,21)/t9-,11-,12-,13-/m1/s1

Synonyms: Uridine, 2',3'-O-(1-methylethylidene)-, 4-oxime, 5'-(2-methylpropanoate); 2',3'-O-(1-Methylethylidene)uridine 4-Oxime 5'-(2-Methylpropanoate); ((3aR,4R,6R,6aR)-6-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate

(2R,3R,4R,5R)-2-((Benzoyloxy)methyl)-5-(4'-chloro-5,5'-diiodo-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-7-yl)tetrahydrofuran-3,4-diyl dibenzoate

Description: (2R,3R,4R,5R)-2-((Benzoyloxy)methyl)-5-(4'-chloro-5,5'-diiodo-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-7-yl)tetrahydrofuran-3,4-diyl dibenzoate is a synthetic compound with potential anti-cancer efficacy. It mainly interferes with DNA replication and transcription, and is used in studies targeting genetic diseases and cancer.

CAT: BRP-01945

MF: C38H25ClI2N6O7

MF: 966.90

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.9±0.1 g/cm3

Boiling Point: 900.4±65.0 °C at 760 mmHg

InChIKey: MYTJWTXUMTUHKX-OAFMTEKMSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)N3C=C(C4=C3N=CN=C4N5C=C(C6=C5N=CN=C6Cl)I)I)OC(=O)C7=CC=CC=C7)OC(=O)C8=CC=CC=C8

IUPAC Name: [(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-[4-(4-chloro-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-5-iodopyrrolo[2,3-d]pyrimidin-7-yl]oxolan-2-yl]methyl benzoate

InChI: InChI=1S/C38H25ClI2N6O7/c39-31-27-24(40)16-46(32(27)43-19-42-31)33-28-25(41)17-47(34(28)45-20-44-33)35-30(54-38(50)23-14-8-3-9-15-23)29(53-37(49)22-12-6-2-7-13-22)26(52-35)18-51-36(48)21-10-4-1-5-11-21/h1-17,19-20,26,29-30,35H,18H2/t26-,29-,30-,35-/m1/s1

Synonyms: 4'-Chloro-5,5'-diiodo-7-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine

2,4-Dithiouridine

Description: 2,4-Dithiouridine is a valuable modified nucleoside used in biochemical, pharmacological, and chemical biology research. Its sulfur substitution at the 2 and 4 positions of the uracil base allows scientists to study the effects of such modifications on nucleotide function, RNA structure, and potential therapeutic applications. This compound provides insights into the role of modified nucleosides in various biological processes and aids in the development of novel therapeutic agents and research tools.

CAT: BRP-01946

CAS: 13239-96-8

MF: C9H12N2O4S2

MF: 276.33

Purity: 98%

Appearance: Yellow Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.73±0.1 g/cm3

Melting Point: >146 °C

Boiling Point: 511.7±60.0 °C at 760 mmHg

InChIKey: OKYRYFXQZRFDQL-XVFCMESISA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

CanonicalSMILES: C1=CN(C(=S)NC1=S)C2C(C(C(O2)CO)O)O

IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dithione

InChI: InChI=1S/C9H12N2O4S2/c12-3-4-6(13)7(14)8(15-4)11-2-1-5(16)10-9(11)17/h1-2,4,6-8,12-14H,3H2,(H,10,16,17)/t4-,6-,7-,8-/m1/s1

Synonyms: 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dithione; 2,4-Dithio-uridine

1-Methyladenosine hydroiodide

Description: 1-Methyladenosine hydroiodide is a valuable modified nucleoside used in biochemical, pharmacological, and chemical biology research. Its methylation at the N1 position and presence as a hydroiodide salt allows scientists to study the effects of such modifications on nucleotide function, RNA structure, and potential therapeutic applications. This compound provides insights into the role of modified nucleosides in various biological processes and aids in the development of novel therapeutic agents and research tools.

CAT: BRP-01947

CAS: 34308-25-3

MF: C11H16IN5O4

MF: 409.18

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.88g/cm3

InChIKey: HRVIETAHBNHGAH-YCSZXMBFSA-N

CanonicalSMILES: CN1C=NC2=C(C1=N)N=CN2C3C(C(C(O3)CO)O)O.I

IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methylpurin-9-yl)oxolane-3,4-diol;hydroiodide

InChI: InChI=1S/C11H15N5O4.HI/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11;/h3-5,7-8,11-12,17-19H,2H2,1H3;1H/t5-,7-,8-,11-;/m1./s1

Synonyms: N1-Methyladenosine hydroiodide; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-imino-1-methyl-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diol hydroiodide; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol hydroiodide; Adenosine, 1-methyl-, hydriodide (1:1); 6-Amino-1-methyl-9-β-D-ribofuranosyl-9H-purinium iodide; Adenosine, 1-methyl-, monohydriodide; NSC 66391

Related CAS: 15763-06-1 (free base)

(E)-N'-(9-((2R,3R,4R,5R)-4-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-((tert-butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide

Description: (E)-N'-(9-((2R,3R,4R,5R)-4-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-((tert-butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide, a powerful anticancer drug, effectively targets cancer cells by disrupting DNA replication. By inhibiting DNA polymerase, it interrupts the essential process of cell division, thus making it an effective chemotherapy drug against various tumors. This compound displays immense potential as a potent antineoplastic agent and holds significant promise for advanced cancer treatment.

CAT: BRP-01948

MF: C40H50N6O7Si

MF: 754.95

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.2±0.1 g/cm3

InChIKey: CTUAKQKWOFVGMG-UWPHNAITSA-N

CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N=CN(C)C)CO)OC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N'-[9-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-3-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide

InChI: InChI=1S/C40H50N6O7Si/c1-39(2,3)54(8,9)53-34-33(31(23-47)51-37(34)46-25-41-32-35(46)43-38(44-36(32)48)42-24-45(4)5)52-40(26-13-11-10-12-14-26,27-15-19-29(49-6)20-16-27)28-17-21-30(50-7)22-18-28/h10-22,24-25,31,33-34,37,47H,23H2,1-9H3,(H,43,44,48)/b42-24+/t31-,33-,34-,37-/m1/s1

Synonyms: (E)-N'-(9-((2R,3R,4R,5R)-4-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-((tert-butyl Dimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethyl formamidine

SDZ WAG 994

Description: SDZ WAG 994 is a potent and selective adenosine A1 receptor agonist (Ki = 23, > 10000 and 25000 nM for A1, A2A and A2B receptors, respectively). SDZ WAG 994 has been shown to lower blood pressure levels and heart rate in spontaneous hypertensive rats, and inhibit adenosine deaminase-stimulated lipolysis in rat adipocytes (Ki = 8 nM).

CAT: BRP-01949

CAS: 130714-47-5

MF: C17H25N5O4

MF: 363.41

Purity: ≥99% by HPLC

Appearance: Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.59±0.1 g/cm3

Boiling Point: 647.2±65.0°C at 760 mmHg

InChIKey: JAKAFSGZUXCHLF-LSCFUAHRSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: COC1C(C(OC1N2C=NC3=C2N=CN=C3NC4CCCCC4)CO)O

IUPAC Name: (2R,3R,4R,5R)-5-[6-(cyclohexylamino)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

InChI: InChI=1S/C17H25N5O4/c1-25-14-13(24)11(7-23)26-17(14)22-9-20-12-15(18-8-19-16(12)22)21-10-5-3-2-4-6-10/h8-11,13-14,17,23-24H,2-7H2,1H3,(H,18,19,21)/t11-,13-,14-,17-/m1/s1

Synonyms: SDZ-WAG994; Adenosine, N-cyclohexyl-2'-O-methyl-; N-Cyclohexyl-2'-O-methyladenosine; SDZ-WAG 994; WAG 994; N6-cyclohexyl-2-O-methyladenosine; SDZ-WAG-994; (2R,3R,4R,5R)-5-(6-(cyclohexylamino)-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol

8-Oxoadenosine

Description: It is an anticancer antibiotic, oxidized nucleic acid adduct and phosmidosine precursor (P-prodrug). It can be used to treat hemochromatosis.

CAT: BRP-01950

CAS: 29851-57-8

MF: C10H13N5O5

MF: 283.24

Purity: ≥95%

Appearance: White to Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C under inert atmosphere

Density: 1.806±0.06 g/cm3

Melting Point: >228°C (dec.)

Boiling Point: 776.3°C at 760 mmHg

InChIKey: UEHOMUNTZPIBIL-UUOKFMHZSA-N

Solubility: Soluble in DMSO (Slightly, Sonicated), Methanol (Very Slightly, Sonicated), Water (Slightly)

CanonicalSMILES: C1=NC(=C2C(=N1)N(C(=O)N2)C3C(C(C(O3)CO)O)O)N

IUPAC Name: 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purin-8-one

InChI: InChI=1S/C10H13N5O5/c11-7-4-8(13-2-12-7)15(10(19)14-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H,14,19)(H2,11,12,13)/t3-,5-,6-,9-/m1/s1

Synonyms: NSC 102240; NSC 90396; 7,8-Dihydro-8-oxoadenosine; 8-Hydroxyadenosine; 8-Oxo-7,8-dihydroadenosine; 6-Amino-7,9-dihydro-9-β-D-ribofuranosyl-8H-purin-8-one; 6-amino-9-(beta-D-ribofuranosyl)purin-8-(7H)-one; (2R,3R,4S,5R)-2-(6-amino-8-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 8-Hydroxyadenosine

N-[1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,2-dihydro-5-iodo-2-oxo-4-pyrimidinyl]benzamide

Description: N-[1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,2-dihydro-5-iodo-2-oxo-4-pyrimidinyl]benzamide, a biomedical compound, is known for its potent action against cancer. It functions as an enzymatic inhibitor, targeting cancerous cells that proliferate with great intensity. It outperforms other treatments when administered against multiple cancer forms. Breast cancer, lung cancer, and melanoma are among the diseases that this drug effectively curbs.

CAT: BRP-01952

CAS: 171721-05-4

MF: C30H23FIN3O7

MF: 683.42

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.62±0.1 g/cm3

InChIKey: JLSSGKUNYKOIPA-LAOBSVPGSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(=O)NC2=NC(=O)N(C=C2I)C3C(C(C(O3)COC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)F

IUPAC Name: [(2S,3S,4R,5S)-5-(4-benzamido-5-iodo-2-oxopyrimidin-1-yl)-3-benzoyloxy-4-fluorooxolan-2-yl]methyl benzoate

InChI: InChI=1S/C30H23FIN3O7/c31-23-24(42-29(38)20-14-8-3-9-15-20)22(17-40-28(37)19-12-6-2-7-13-19)41-27(23)35-16-21(32)25(34-30(35)39)33-26(36)18-10-4-1-5-11-18/h1-16,22-24,27H,17H2,(H,33,34,36,39)/t22-,23+,24-,27-/m0/s1

Synonyms: Benzamide, N-[1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,2-dihydro-5-iodo-2-oxo-4-pyrimidinyl]-; (2S,3S,4R,5S)-5-(4-benzamido-5-iodo-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluorotetrahydrofuran-3-yl benzoate; (3R,4S)-5-(4-benzamido-5-iodo-2-oxopyrimidin-1(2H)-yl)-2-(benzoyloxymethyl)-4-fluorotetrahydrofuran-3-yl benzoate

S-Adenosyl-L-methionine chloride

Description: S-Adenosyl-L-methionine chloride (SAM or SAMe) is a vital compound in biochemical and pharmacological research due to its role as a methyl group donor in methylation reactions and its function as a cofactor for numerous enzymes. It is significant in studies related to gene regulation, enzyme mechanisms, and therapeutic applications for depression, liver diseases, and joint health. Additionally, SAMe's availability as a dietary supplement highlights its potential benefits in promoting overall health and well-being.

CAT: BRP-01953

CAS: 24346-00-7

MF: C15H23ClN6O5S

MF: 434.90

Purity: 98%

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Application: This material is 80-90% pure when prepared, but is very unstable. Methyl donor; cofactor for enzyme-catalyzed methylations, including catechol O-methyltransferase (COMT) and DNA methyltransferases (DNMT). Although present in all cells, it is concentrated

InChIKey: DYFPQIYEZQULMZ-XKGORWRGSA-N

Solubility: Soluble in Water

CanonicalSMILES: C[S+](CCC(C(=O)O)N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.[Cl-]

IUPAC Name: [(3S)-3-amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium;chloride

InChI: InChI=1S/C15H22N6O5S.ClH/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21;/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25);1H/t7-,8+,10+,11+,14+,27?;/m0./s1

Synonyms: Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methylsulfonio]-5'-deoxy-, chloride (1:1); Adenosine, 5'-[(3-amino-3-carboxypropyl)methylsulfonio]-5'-deoxy-, chloride; Adenosine, 5'-[(3-amino-3-carboxypropyl)methylsulfonio]-5'-deoxy-, chloride, (3S)-; Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methylsulfonio]-5'-deoxy-, chloride; Methionine, S-(5-deoxyadenos-5-yl)-, chloride, L-; S-(5-Adenosyl)-L-methionine chloride; S-Adenosylmethionine chloride

Related CAS: 485-80-3 (free base)

2,2'-Anhydro-5'-O-t-butyldiphenylsilyluridine

Description: 2,2'-Anhydro-5'-O-t-butyldiphenylsilyluridine, a remarkable biomedicine, emerges as an invaluable asset in combatting the peril of viral infections, with a precise focus on RNA viruses. As a potent nucleoside analogue, it exerts its therapeutic prowess by skillfully impeding viral replication through the disruption of viral RNA synthesis. Possessing unparalleled efficacy, this exceptional product stands as a formidable antiviral warrior, fiercely combating a myriad of illnesses caused by RNA viruses such as influenza, HIV, and hepatitis C.

CAT: BRP-01957

CAS: 175013-46-4

MF: C25H28N2O5Si

MF: 464.59

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.3±0.1 g/cm3

Melting Point: 181-182 °C

Boiling Point: 558.0±60.0°C at 760 mmHg

InChIKey: LDJBSUUNUJOJTI-XBYSBRQOSA-N

CanonicalSMILES: CC(C)(C)[Si](C1=CC=CC=C1)(C2=CC=CC=C2)OCC3C(C4C(O3)N5C=CC(=O)N=C5O4)O

IUPAC Name: (2R,3R,3aS,9aR)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-3-hydroxy-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one

InChI: InChI=1S/C25H28N2O5Si/c1-25(2,3)33(17-10-6-4-7-11-17,18-12-8-5-9-13-18)30-16-19-21(29)22-23(31-19)27-15-14-20(28)26-24(27)32-22/h4-15,19,21-23,29H,16H2,1-3H3/t19-,21-,22+,23-/m1/s1

Synonyms: 5'-O-TBDPS-2,2'-anhydrouridine; 5'-O-(tert-butyldiphenylsilyl)-2,2'-O-anhydrouridine; (2R,4R,5R,6S)-4-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-hydroxy-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one; (2R)-2alpha-[(tert-Butyldiphenylsiloxy)methyl]-3beta-hydroxy-2,3,3abeta,9abeta-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; (2R,3R,3aS,9aR)-2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-, [2R-(2α,3β,3aβ,9aβ)]-

5'-O-Benzoyl-2,2'-anhydrouridine

Description: 5'-O-Benzoyl-2,2'-anhydrouridine is a modified nucleoside used in nucleic acid research and chemical synthesis. This compound has a benzoyl group protecting the 5'-hydroxyl position and an anhydro linkage between the 2' and 2'' positions of uridine. The modification can enhance the stability and alter the properties of nucleic acids. It is particularly useful in the synthesis of oligonucleotides and in studies involving RNA structure and function. The presence of the anhydro linkage can help in the formation of specific conformations, making it a valuable tool for probing the biochemical and biophysical properties of RNA.

CAT: BRP-01958

CAS: 24877-18-7

MF: C16H14N2O6

MF: 330.29

Purity: 95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.62±0.1 g/cm3

Melting Point: 198-200 °C

Boiling Point: 522.6±60.0 °C at 760 mmHg

InChIKey: UDIXPZFDRWDWAJ-RUZUBIRVSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C3C(O2)N4C=CC(=O)N=C4O3)O

IUPAC Name: [(2R,4R,5R,6S)-5-hydroxy-10-oxo-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-4-yl]methyl benzoate

InChI: InChI=1S/C16H14N2O6/c19-11-6-7-18-14-13(24-16(18)17-11)12(20)10(23-14)8-22-15(21)9-4-2-1-3-5-9/h1-7,10,12-14,20H,8H2/t10-,12-,13+,14-/m1/s1

Synonyms: ((2R,3R,3aS,9aR)-3-hydroxy-6-oxo-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-2-yl)methyl benzoate; 5'-O-Benzoyl-2,2'-anhydro-D-uridine; (2R,3R,3aS,9aR)-2-[(Benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; 6H-Furo[2',3':4,5]oxazolo[3,2-c]pyrimidin-6-one, 2-[(benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-, [2R-(2α,3β,3aβ,9aβ)]-

5'-O-Benzyl-2,2'-anhydrouridine

Description: 5'-O-Benzyl-2,2'-anhydrouridine, an acclaimed biomedicine, displays its prowess in combating both viral infections and cancer. By impeding viral replication and inducing apoptosis in cancerous cells, it manifests itself as both an antiviral and antineoplastic agent.

CAT: BRP-01959

CAS: 2410993-94-9

MF: C16H16N2O5

MF: 316.31

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.53±0.1 g/cm3

Boiling Point: 505.4±60.0 °C at 760 mmHg

InChIKey: SIIADAUAAHGNDX-REBRKWNGSA-N

CanonicalSMILES: O=C1N=C2OC3C(O)C(OC3N2C=C1)COCC=4C=CC=CC4

IUPAC Name: (2R,3R,3aS,9aR)-2-((benzyloxy)methyl)-3-hydroxy-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one

InChI: InChI=1S/C16H16N2O5/c19-12-6-7-18-15-14(23-16(18)17-12)13(20)11(22-15)9-21-8-10-4-2-1-3-5-10/h1-7,11,13-15,20H,8-9H2/t11-,13-,14+,15-/m1/s1

Synonyms: 5'-O-Benzyl-2,2'-anhydro-D-uridine; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-[(phenylmethoxy)methyl]-, (2R,3R,3aS,9aR)-; (2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-[(phenylmethoxy)methyl]-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one

2,6-Diamino-9-(β-D-arabinofuranosyl)purine

Description: 2,6-Diamino-9-(β-D-arabinofuranosyl)purine, a potent antineoplastic agent, is indicated for the management of chronic lymphocytic leukemia and non-Hodgkin lymphoma. By restraining DNA synthesis, the agent induces apoptosis in rapidly proliferating cancerous cells. Its potential as an efficacious chemotherapeutic has been well-establish through extensive clinical data.

CAT: BRP-01960

CAS: 34079-68-0

MF: C10H14N6O4

MF: 282.26

Purity: ≥95%

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 2.25±0.10 g/cm3

Melting Point: 286-290 °C

Boiling Point: 798.5±70.0 °C at 760 mmHg

InChIKey: ZDTFMPXQUSBYRL-FJFJXFQQSA-N

CanonicalSMILES: C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)N)N

IUPAC Name: (2R,3S,4S,5R)-2-(2,6-diaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H14N6O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H4,11,12,14,15)/t3-,5-,6+,9-/m1/s1

Synonyms: DAPA; 2,6-Diamino-9-(b-D-arabinofuranosyl)purine; 2,6-Diaminopurine-9-arabinoside; araDAP; araDAPR; (2R,3S,4S,5R)-2-(2,6-Diamino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-β-D-Arabinofuranosyl-9H-purine-2,6-diamine; 2,6-Diamino-9-β-D-arabinofuranosylpurine; 9-β-D-Arabinofuranosyl-2,6-diaminopurine

5-Bromoarabinouridine

Description: 5-Bromoarabinouridine, known for its significant role in biomedical research, emerges as a nucleoside analog warranting attention. Operating as an effective combatant against selected viral infections and cancers, it bestows antiviral and antitumor prowess by impeding viral replication and perturbing DNA synthesis.

CAT: BRP-01961

CAS: 3370-69-2

MF: C9H11BrN2O6

MF: 323.10

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 2.043±0.06 g/cm3

InChIKey: AGFIRQJZCNVMCW-MNCSTQPFSA-N

CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)Br

IUPAC Name: 5-bromo-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C9H11BrN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6+,8-/m1/s1

Synonyms: 1-(β-D-Arabinofuranosyl)-5-bromouracil; 1-(β-D-Arabinofuranosyl)-5-bromo-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-5-bromo-; 5-Bromo-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-β-D-Arabinofuranosyl-5-bromo-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-5-bromo-; 1-β-D-Arabinofuranosyl-5-bromouracil; NSC 82222

5-Iodoarabinouridine

Description: 5-Iodoarabinouridine, a biomedical compound, displays remarkable potential for research of various diseases. Exerting its influence as an RNA research and development inhibitor, this compound takes center stage in the arena of cancer research. Its proficiency lies in the selective targeting of RNA molecules, effectively curbing the malignant growth and propagation of cancer cells.

CAT: BRP-01962

CAS: 3052-06-0

MF: C9H11IN2O6

MF: 370.10

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 2.27±0.1 g/cm3

Melting Point: 196-199 °C

InChIKey: RKSLVDIXBGWPIS-MNCSTQPFSA-N

CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)I

IUPAC Name: 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione

InChI: InChI=1S/C9H11IN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6+,8-/m1/s1

Synonyms: 1-(β-D-Arabinofuranosyl)-5-iodouracil; NSC 82221; I-araU; 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-iodo-; 1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione; 1-β-D-Arabinofuranosyl-5-iodo-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-5-iodo-; 1-β-D-Arabinofuranosyl-5-iodouracil; NSC 82221

N1-Methyl ara-uridine

Description: N1-Methyl ara-uridine is an exceptional compound, holding applications in studying diverse diseases such as cancer. It has the remarkable capability to selectively target malignant cells. By functioning as a robust inhibitor, it obstructs the rampant growth of cancerous cells while facilitating programmed cell death.

CAT: BRP-01963

CAS: 17676-62-9

MF: C10H14N2O6

MF: 258.23

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.605±0.06 g/cm3 (Predicted)

Boiling Point: 501.1±60.0 °C at 760 mmHg

InChIKey: UTQUILVPBZEHTK-BUJSFMDZSA-N

CanonicalSMILES: CN1C(=O)C=CN(C1=O)C2C(C(C(O2)CO)O)O

IUPAC Name: 1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-methylpyrimidine-2,4(1H,3H)-dione

InChI: InChI=1S/C10H14N2O6/c1-11-6(14)2-3-12(10(11)17)9-8(16)7(15)5(4-13)18-9/h2-3,5,7-9,13,15-16H,4H2,1H3/t5-,7-,8+,9-/m1/s1

Synonyms: 2,4(1H,3H)-Pyrimidinedione, 1-β-D-arabinofuranosyl-3-methyl-; 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyrimidine-2,4-dione; 1-beta-D-Arabinofuranosyl-3-methyluracil; 1-(β-D-Arabinofuranosyl)-3-methyl-2,4(1H,3H)-pyrimidinedione; 1-β-D-Arabinofuranosyl-3-methyl-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-3-methyl-; 1-β-D-Arabinofuranosyl-3-methyluracil

N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-aracytidine

Description: N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-aracytidine, a highly esteemed and significant compound extensively employed in the biomedical sector, exhibits immense potential. This geological marvel assumes a paramount position in combating viral afflictions, encompassing select strains of herpes and malignancies attributed to viral etiology.

CAT: BRP-01964

CAS: 87418-76-6

MF: C37H35N3O8

MF: 649.69

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.31±0.1 g/cm3

InChIKey: KCLOEKUQZJAMFG-RWJNZVCKSA-N

CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)O)O

IUPAC Name: N-(1-((2R,3S,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

InChI: InChI=1S/C37H35N3O8/c1-45-28-17-13-26(14-18-28)37(25-11-7-4-8-12-25,27-15-19-29(46-2)20-16-27)47-23-30-32(41)33(42)35(48-30)40-22-21-31(39-36(40)44)38-34(43)24-9-5-3-6-10-24/h3-22,30,32-33,35,41-42H,23H2,1-2H3,(H,38,39,43,44)/t30-,32-,33+,35-/m1/s1

Synonyms: N-(1-{(2R,3S,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-3,4-dihydroxy-tetrahydro-furan-2-yl}-2-oxo-1,2-dihydro-pyrimidin-4-yl)-benzamide; N-Benzoyl-5'-(di-p-methoxytrityl)aracytidine; N-[1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-β-D-arabinofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide; N4-Bz-5'-O-DMT-araC

Adenosine HCl

Description: Adenosine hydrochloride is a hydrochloride salt form of adenosine, a nucleoside composed of adenine and ribose. Adenosine plays a crucial role in biochemical processes such as energy transfer (e.g., ATP) and signal transduction as a neurotransmitter. In its monohydrochloride form, adenosine is more soluble in water, making it useful for various biochemical and pharmaceutical applications. This compound is employed in research focused on cellular metabolism, enzyme functions, and nucleic acid interactions. Additionally, adenosine monohydrochloride is used in studies investigating the effects of adenosine on cardiovascular and neurological functions.

CAT: BRP-01965

CAS: 58056-57-8

MF: C10H13N5O4.xHCl

MF: 267.24 (free base)

Purity: ≥98% by HPLC

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: YFJCRJZTDYDCRZ-MCDZGGTQSA-N

CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.Cl

IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrochloride

InChI: InChI=1S/C10H13N5O4.ClH/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H/t4-,6-,7-,10-;/m1./s1

Synonyms: Adenosine hydrochloride; Adenosine hydrochloride (1:x); (2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hydrochloride; 9-β-D-Ribofuranosyl-9H-purin-6-amine hydrochloride; 9-β-D-Ribofuranosyladenine hydrochloride; D-Adenosine hydrochloride; Adenine riboside hydrochloride; β-D-Adenosine hydrochloride; β-Adenosine hydrochloride

Related CAS: 58-61-7 (free base) ; 19065-22-6 (monohydrochloride )

N4-Benzoyl-L-cytidine

Description: N4-Benzoyl-L-cytidine, an innovative biomedical compound, showcases promising applications in therapeutic settings. With a primary focus on breast and colon cancers, its utilization proves pivotal in curtailing tumor progression and bolstering cancer cell apoptosis. Broadening horizons for biomedical research, this indispensable entity's extraordinary chemical attributes lay the foundation for creating precise, targeted therapies catering to distinct cancer subtypes.

CAT: BRP-01966

CAS: 1018812-31-1

MF: C16H17N3O6

MF: 347.32

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.59±0.1 g/cm3

InChIKey: BNXBRFDWSPXODM-NHULGOKLSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(=O)NC2=NC(=O)N(C=C2)C3C(C(C(O3)CO)O)O

IUPAC Name: N-[1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C16H17N3O6/c20-8-10-12(21)13(22)15(25-10)19-7-6-11(18-16(19)24)17-14(23)9-4-2-1-3-5-9/h1-7,10,12-13,15,20-22H,8H2,(H,17,18,23,24)/t10-,12-,13-,15-/m0/s1

Synonyms: N-Benzoyl-L-cytidine; N4-Benzoylcytidine; N-(1,2-Dihydro-2-oxo-1-β-L-ribofuranosyl-4-pyrimidinyl)benzamide; N-(1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide; L-C(Bz)